Your browser is no longer supported. Please, upgrade your browser.
TTNP [NASD]
Titan Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-7.40 Insider Own5.08% Shs Outstand9.86M Perf Week-17.73%
Market Cap34.00M Forward P/E- EPS next Y-3.51 Insider Trans0.00% Shs Float5.29M Perf Month-2.62%
Income-19.10M PEG- EPS next Q-1.33 Inst Own3.60% Short Float24.86% Perf Quarter-39.49%
Sales5.00M P/S6.80 EPS this Y7.90% Inst Trans52.40% Short Ratio0.71 Perf Half Y-53.51%
Book/sh-0.27 P/B- EPS next Y43.90% ROA-188.30% Target Price- Perf Year-45.48%
Cash/sh0.40 P/C8.29 EPS next 5Y- ROE- 52W Range2.82 - 16.35 Perf YTD1.52%
Dividend- P/FCF- EPS past 5Y3.20% ROI-307.70% 52W High-79.75% Beta1.06
Dividend %- Quick Ratio0.90 Sales past 5Y-0.20% Gross Margin67.30% 52W Low17.42% ATR0.38
Employees21 Current Ratio1.10 Sales Q/Q22.20% Oper. Margin- RSI (14)44.56 Volatility10.43% 10.26%
OptionableYes Debt/Eq- EPS Q/Q72.10% Profit Margin- Rel Volume0.62 Prev Close3.34
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume1.86M Price3.31
Recom2.00 SMA20-9.17% SMA50-3.11% SMA200-45.25% Volume1,111,592 Change-0.86%
Jun-26-19Initiated Maxim Group Buy $4
Nov-10-17Downgrade ROTH Capital Buy → Neutral
Feb-01-21 07:30AM  
Jan-15-21 09:15AM  
Dec-16-20 08:00AM  
Dec-01-20 04:56AM  
Nov-30-20 12:50PM  
Nov-16-20 08:45AM  
Nov-02-20 08:00AM  
Oct-30-20 08:14AM  
Oct-28-20 03:00PM  
08:00AM  
Oct-26-20 06:30AM  
Oct-15-20 08:00AM  
Sep-24-20 09:00AM  
Sep-18-20 04:45PM  
Sep-16-20 01:05PM  
Sep-15-20 08:30AM  
Sep-14-20 08:30AM  
Aug-26-20 05:45AM  
Aug-14-20 08:45AM  
Aug-10-20 04:30PM  
Jul-08-20 08:00AM  
Jun-24-20 08:00AM  
Jun-16-20 08:00AM  
Jun-01-20 05:20AM  
May-15-20 08:45AM  
May-11-20 04:03PM  
Apr-09-20 06:15AM  
Apr-02-20 09:47PM  
Mar-31-20 12:43PM  
Mar-30-20 04:03PM  
02:30PM  
Mar-26-20 08:00AM  
Mar-05-20 09:00AM  
Feb-18-20 08:55AM  
Jan-13-20 08:00AM  
Jan-07-20 09:15AM  
Dec-30-19 08:00AM  
Dec-17-19 10:30AM  
Dec-04-19 01:22PM  
Dec-03-19 09:00AM  
Nov-25-19 05:15AM  
Nov-14-19 04:03PM  
Nov-07-19 04:30PM  
Oct-22-19 08:00AM  
Oct-18-19 10:23AM  
Oct-16-19 09:20AM  
Oct-01-19 08:00AM  
Sep-18-19 08:00AM  
Aug-30-19 08:01PM  
Aug-23-19 11:30AM  
Aug-17-19 09:59AM  
Aug-16-19 07:33AM  
Aug-14-19 04:03PM  
07:32AM  
Aug-09-19 05:00PM  
Aug-07-19 09:15AM  
Jul-09-19 09:00AM  
Jul-03-19 10:54AM  
Jun-26-19 09:10AM  
Jun-04-19 07:00AM  
May-29-19 02:15PM  
May-23-19 08:10AM  
May-15-19 04:08PM  
04:03PM  
May-13-19 07:00AM  
May-08-19 08:00PM  
May-06-19 03:12PM  
Apr-29-19 07:00AM  
Apr-12-19 05:00PM  
Apr-11-19 09:45AM  
Apr-02-19 01:06AM  
Apr-01-19 05:07PM  
04:30PM  
Mar-28-19 07:00AM  
Mar-26-19 07:00AM  
Feb-25-19 02:20PM  
07:00AM  
Feb-08-19 09:30AM  
Feb-01-19 02:31PM  
12:01PM  
11:46AM  
11:10AM  
Jan-31-19 06:36PM  
Jan-24-19 07:00AM  
Dec-21-18 12:54PM  
Dec-10-18 10:35AM  
Nov-21-18 07:25AM  
Nov-20-18 11:15AM  
Nov-14-18 04:38PM  
04:01PM  
Nov-08-18 07:00AM  
Nov-07-18 09:30AM  
Nov-05-18 08:55AM  
07:00AM  
Nov-02-18 10:30AM  
Oct-30-18 09:45AM  
Oct-29-18 08:00AM  
Oct-23-18 02:40PM  
Oct-22-18 08:00AM  
Oct-15-18 08:15AM  
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company also develops ProNeura-Ropinirole, an implant to provide delivery of ropinirole, a dopamine agonist for the treatment of Parkinson's disease; and triiodothyronine, an implant for the treatment of hypothyroidism. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California.